Robert A. Greenwald
11Patents
11h-index
25Co-inventors
68Inventor score
Filing activity: Jun 28, 1990 → Feb 28, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5789395A | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production | Emerging Cross-Sectional Technologies | 100 | Expired |
| US6841547B2 | Method for decreasing low density lipoprotein | Human Necessities | 87 | Expired |
| US5258371A | Method to reduce connective tissue destruction | Human Necessities | 47 | Expired |
| US5045538A | Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines | Human Necessities | 44 | Expired |
| US6043231A | Inhibition of excessive phospholipase A.sub.2 activity and/or production by non-antimicrobial tetracyclines | Emerging Cross-Sectional Technologies | 43 | Expired |
| US5459135A | Composition comprising indomethacin [non-steroidal anti-inflammatory agent] and effectively non-antibacterial tetracycline to reduce bone loss | Human Necessities | 36 | Expired |
| US5308839A | Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline | Human Necessities | 36 | Expired |
| US5321017A | Composition comprising fluriprofen and effectively non-antibacterial tetracycline to reduce bone loss | Human Necessities | 33 | Expired |
| US5919775A | Method for inhibiting expression of inducible nitric oxide synthase with tetracycline | Emerging Cross-Sectional Technologies | 33 | Expired |
| US5523297A | Inhibition of excessive phospholipase A.sub.2 activity and/or production by non-antimicrobial tetracyclines | Human Necessities | 31 | Expired |
| US6015804A | Method of using tetracycline compounds to enhance interleukin-10 production | Human Necessities | 25 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.